Data as of Apr 17
| -0.94 / -0.32%|
The 25 analysts offering 12-month price forecasts for Biogen Idec Inc have a median target of 352.00, with a high estimate of 422.00 and a low estimate of 262.00. The median estimate represents a +21.15% increase from the last price of 290.54.
The current consensus among 29 polled investment analysts is to Buy stock in Biogen Idec Inc. This rating has held steady since April, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.